Immunogenicity and safety of SARS-CoV-2 recombinant spike protein vaccine in South African people living with and without HIV-1 infection: A phase 2 randomised trial

Autor: Bennett, Chijioke, Hoosain, Zaheer, Koen, Anthonet, Lalloo, Umesh, Louw, Cheryl, Maluleke, Vongane, Patel, Faeezah, Benade, Gabriella, Venter, Esme Louise, Galbiati, Shirley, Shinde, Vivek, Madhi, Shabir A.
Zdroj: In Journal of Infection December 2024 89(6)
Databáze: ScienceDirect